Metabolic Neuropathy Differential Diagnoses
- Author: Tarakad S Ramachandran, MBBS, FRCP(C), FACP; Chief Editor: Nicholas Lorenzo, MD more...
Differential Diagnoses
- Acute Inflammatory Demyelinating Polyradiculoneuropathy
- Alcohol (Ethanol) Related Neuropathy
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Diabetic Neuropathy
- HIV-1 Associated Acute/Chronic Inflammatory Demyelinating Polyneuropathy
- HIV-1 Associated Distal Painful Sensorimotor Polyneuropathy
- Meralgia Paresthetica
- Neuronal Ceroid Lipofuscinoses
- Neuropathy of Friedreich Ataxia
- Neuropathy of Leprosy
- Neurosarcoidosis
- Neurosyphilis
- Nutritional Neuropathy
- Peroneal Mononeuropathy
- Polyarteritis Nodosa
- Postherpetic Neuralgia
- Radiation Necrosis
- Sarcoidosis and Neuropathy
- Toxic Neuropathy
- Varicella Zoster
- Vasculitic Neuropathy
Tamborlane WV, Ahern J. Implications and results of the Diabetes Control and Complications Trial. Pediatr Clin North Am. Apr 1997;44(2):285-300. [Medline].
Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, et al. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep. Aug 2010;10(4):276-82. [Medline].
Greene DA, Stevens MJ, Feldman EL. Diabetic neuropathy: scope of the syndrome. Am J Med. Aug 30 1999;107(2B):2S-8S. [Medline].
Voulgari C, Psallas M, Kokkinos A, Argiana V, Katsilambros N, Tentolouris N. The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes. J Diabetes Complications. May-Jun 2011;25(3):159-67. [Medline].
Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology. Dec 10 1999;53(9):2113-21. [Medline].
Harati Y. Frequently asked questions about diabetic peripheral neuropathies. Neurol Clin. Aug 1992;10(3):783-807. [Medline].
Pirart J. [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl)]. Diabete Metab. Dec 1977;3(4):245-56. [Medline].
Arezzo JC. New developments in the diagnosis of diabetic neuropathy. Am J Med. Aug 30 1999;107(2B):9S-16S. [Medline].
Chalk CH. Acquired peripheral neuropathy. Neurol Clin. Aug 1997;15(3):501-28. [Medline].
Dick PJ, Thomas PK, eds. Peripheral Neuropathy. 3rd ed. Philadelphia: WB Saunders Co; 1993.
Comi G, Corbo M. Metabolic neuropathies. Curr Opin Neurol. Oct 1998;11(5):523-9. [Medline].
Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: Dick PJ, Thomas PK, eds. Peripheral Neuropathy. Philadelphia: WB Saunders Co; 1993:1221.
Apfel SC. Neurotrophic factors in the therapy of diabetic neuropathy. Am J Med. Aug 30 1999;107(2B):34S-42S. [Medline].
Misiunas A, Niepomniszcze H, Ravera B, et al. Peripheral neuropathy in subclinical hypothyroidism. Thyroid. Aug 1995;5(4):283-6. [Medline].
Kyle RA. Monoclonal proteins in neuropathy. Neurol Clin. Aug 1992;10(3):713-34. [Medline].
Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F, et al. Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med. Mar 9 2006;354(10):1021-30. [Medline].
Simmons DN, Lisle DA, Linklater JM. Imaging of Peripheral Nerve Lesions in the Lower Limb. Techniques in Foot & Ankle Surgery. 2008/12;7(4):224-237.
Lisle DA, Johnstone SA. Usefulness of muscle denervation as an MRI sign of peripheral nerve pathology. Australas Radiol. Dec 2007;51(6):516-26. [Medline].
Krishnan AV, Lin CS, Park SB, Kiernan MC. Assessment of nerve excitability in toxic and metabolic neuropathies. J Peripher Nerv Syst. Mar 2008;13(1):7-26. [Medline].
Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. Dec 1999;83(3):389-400. [Medline].
Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care. Jul 2008;31(7):1448-54. [Medline].
Azoulay D, Samuel D, Castaing D, et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. J Am Coll Surg. Dec 1999;189(6):584-93. [Medline].
Kaminski HJ, Ruff RL. Neurologic complications of endocrine diseases. Neurol Clin. Aug 1989;7(3):489-508. [Medline].
Burn DJ, Bates D. Neurology and the kidney. J Neurol Neurosurg Psychiatry. Dec 1998;65(6):810-21. [Medline].
Lagueny A. [Metabolic and nutritional neuropathies]. Rev Prat. Apr 1 2000;50(7):731-5. [Medline].
Parry GJ. Management of diabetic neuropathy. Am J Med. Aug 30 1999;107(2B):27S-33S. [Medline].
| Small-Fiber Sensory | Large-Fiber Sensory | Autonomic |
| Burning pain | Loss of vibration | Heart rate changes |
| Cutaneous allodynia | Proprioception loss | Postural blood pressure change |
| Paresthesias | Loss of reflexes | Abnormal sweating |
| Lancinating pain | Slowed NCVs | Gastroparesis |
| Loss pain/temperature | Sensory ataxia | Impotence |
| Foot ulcers | Weakness | Abnormal ejaculation |
| Visceral pain loss | ||
| * Modified from Apfel, 1999.[13] | ||

